Form 4 for STLN Starling Oncology, Inc.
Accepted 2026-04-13 09:03:52 ET · period of report 2026-04-09 · accession 0000921895-26-000958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-13 09:03 | 2026-04-09 | STLN | Chernett Jorey | 10% | P - Purchase | $3.10 | +20.0K | 10.50M | +0.2% | +$62.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-09 | P | A | 20,000 | $3.10 | 10,499,358 | D | — | — |